On Thursday, Cathie Wood-led Ark Invest made a series of trades, with the most prominent being the sale of Tesla Inc shares.
The TSLA Trade
Ark Invest sold 85,456 Tesla shares from its ARK Innovation ETF and ARK Autonomous Technology & Robotics ETF, a transaction valued at $22.22 million based on Tesla’s closing price of $260.48 per share. On Thursday, Tesla stock skyrocketed 21.9%. The sale comes amidst Tesla’s surprising third-quarter earnings, which beat estimates and showed improving margins. The electric vehicle giant also shared a strong vehicle delivery outlook for 2025, which was among the highlights for analysts. This information was disclosed during the earnings call, where Tesla CEO Elon Musk shared more details than usual.
Earlier in July, Musk had endorsed Ark Invest’s $5 trillion valuation forecast for Tesla, suggesting it may be conservative. He cited the potential of the Optimus humanoid robot, estimating a global demand of over 20 billion units for both consumer and industrial applications.
Notably, in August, Ark Invest had unloaded $21million worth of Tesla stock.
Other Key Trades:
Ark Invest’s ARKG ETF sold shares of Vertex Pharmaceuticals Inc . Both ARKG and ARKK ETFs bought shares of CRISPR Therapeutics AG .
Intellia Therapeutics Inc shares were also bought by ARKG and ARKK. ARKG bought shares of Cerus Corp . ARKK and ARKQ ETFs bought shares of Teradyne Inc .
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.